非洲猪瘟疫苗研究进展

doi:10.12160/j.issn.1672-5190.2022.01.019

摘要/Abstract

摘要： 非洲猪瘟（African swine fever,ASF）是由非洲猪瘟病毒（African swine fever virus,ASFV）引起的家猪和野猪的急性、出血性传染病,强毒株感染猪的致死率接近100%,给养猪业造成巨大经济损失。ASFV在猪群中可以快速有效传播,在环境中可稳定存在,为ASF的防控带来了挑战。研究人员一直致力于ASF疫苗的研究,迄今为止,仍没有有效的疫苗投入市场。综述了ASF灭活疫苗、减毒活疫苗、亚单位疫苗、DNA疫苗、病毒活载体疫苗的研究情况,以期为ASF疫苗的有效研发提供参考。

关键词: 非洲猪瘟, 疫苗, 研发进展

Abstract: African swine fever （ASF） is an acute and hemorrhagic infectious disease caused by the African swine fever virus （ASFV） in farmed pigs and wild boars. Pigs infected with a highly virulent ASFV strain have a near 100% mortality rate, resulting in massive economic losses for the pig industry. ASFV spreads quickly and effectively in pigs and persists in the environment, posing challenges for prevention and control of ASF. The development of ASF vaccine has been a priority for researchers. There hasn′t been a successful vaccine on the market yet. In order to give a reference for successful research and development of ASF vaccine, this paper reviewed the current research status of ASF inactivated vaccine, live attenuated vaccine, subunit vaccine, DNA vaccine, and live viral vector vaccine.

Key words: African swine fever, vaccine, research and development progress

中图分类号:

李运娜, 王冠, 贾皓, 戴晓光, 苏胜杰, 王旭红. 非洲猪瘟疫苗研究进展[J]. 畜牧与饲料科学, 2022, 43(1): 115-118.

LI Yun-na, WANG Guan, JIA Hao, DAI Xiao-guang, SU Sheng-jie, WANG Xu-hong. Research Progress of African Swine Fever Vaccine[J]. Animal Husbandry and Feed Science, 2022, 43(1): 115-118.

参考文献 32

[1]	WANG N, ZHAO D M,WANG J L, et al.Architecture of African swine fever virus and implications for viral assembly[J].Science,2019,366(6465):640-644.
[2]	刘升. 三种新发再发病毒入侵与组装机制研究[D].北京:中国科学技术大学,2020.
[3]	CHAPMAN D A G, TCHEREPANOV V,UPTON C, et al. Comparison of the genome sequences of non-pathogenic and pathogenic African swine fever virus isolates[J].Journal of General Virology,2008,89(Pt 2):397-408.
[4]	CADENAS-FERNÁNDEZ E,SÁNCHEZ-VIZCAÍNO J M,VAN DEN BORN E,et al.High doses of inactivated African swine fever virus are safe,but do not confer protection against a virulent challenge[J].Vaccines,2021,9(3):242-246.
[5]	STONE S S, HESS W R.Antibody response to inactivated preparations of African swine fever virus in pigs[J]. American Journal of Veterinary Research,1967,28(123):475-481.
[6]	BLOME S, GABRIEL C, BEER M.Modern adjuvants do not enhance the efficacy of an inactivated African swine fever virus vaccine preparation[J].Vaccine,2014,32(31):3879-3882.
[7]	MILIÁN-SUAZO F, GUTIÉRREZ-PABELLO J A, BOJORQUEZ-NARVÁEZ L, et al. IFN-g response to vaccination against tuberculosis in dairy heifers under commercial settings[J].Research in Veterinary Science,2011,90(3):419-424.
[8]	KAUR M, SAXENA A, RAI A, et al.Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB/c mice[J].FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology,2010,24(1):173-183.
[9]	SÁNCHEZ-CORDÓN P J, CHAPMAN D, JABBAR T, et al. Different routes and doses influence protection in pigs immunised with the naturally attenuated African swine fever virus isolate OURT88/3[J].Antiviral Research,2017,138:1-8.
[10]	GALLARDO C, SÁNCHEZ E G, PÉREZ-NUÑEZ D, et al. African swine fever virus (ASFV) protection mediated by NH/P68 and NH/P68 recombinant live-attenuated viruses[J].Vaccine,2018,36(19):2694-2704.
[11]	BARASONA J A, GALLARDO C, CADENAS-FERNÁNDEZ E, et al. First oral vaccination of Eurasian wild boar against African swine fever virus genotype Ⅱ[J]. Frontiers in Veterinary Science,2019,6:137.
[12]	SÁNCHEZ E G,PÉREZ-NUÑEZ D,REVILLA Y. Development of vaccines against African swine fever virus[J].Virus Research,2019,265:150-155.
[13]	BORCA M V,O′DONNELL V,HOLINKA L, et al. Deletion of CD2-like gene from the genome of African swine fever virus strain Georgia does not attenuate virulence in swine[J].Scientific Reports,2020,10(1):494.
[14]	MONTEAGUDO P L, LACASTA A, LÓPEZ E, et al. BA71ΔCD2: A new recombinant live attenuated African swine fever virus with cross-protective capabilities[J].Journal of Virology,2017,91(21):e01058-17.
[15]	O′DONNELL V, RISATTI G R, HOLINKA L G, et al. Simultaneous deletion of the 9gl and uk genes from the african swine fever virus georgia 2007 isolate offers increased safety and protection against homologous challenge[J].Journal of Virology,2017,91(1):e01760-16.
[16]	CHEN W, ZHAO D, HE X, et al.A seven-gene-deleted African swine fever virus is safe and effective as a live attenuated vaccine in pigs[J].Science China Life Sciences,2020,63(5):623-634.
[17]	ALEXEY D,SEREDA A D,BALYSHEV V M,et al.Protective properties of attenuated strains of African swine fever virus belonging to seroimmunotypes Ⅰ-Ⅷ[J].Pathogens,2020(9):274.
[18]	戈胜强,张潇月,吕艳,等.非洲猪瘟病毒细胞传代致弱株研究进展[J].中国动物检疫,2021,38(6):76-81.
[19]	GO′MEZ-PUERTAS P, RODRI′GUEZ F, OVIEDO J M, et al. The African swine fever virus proteins p54 and p30 are involved in two distinct steps of virus attachment and both contribute to the antibody-mediated protective immune response[J].Virology,1998,243(2):461-471.
[20]	NEILAN J G, ZSAK L, LU Z, et al.Neutralizing antibodies to African swine fever virus proteins p30, p54, and p72 are not sufficient for antibody-mediated protection[J].Virology,2004,319(2):337-342.
[21]	ARGILAGUET J M, PÉREZ-MARTÍN E, GALLARDO C, et al. Enhancing DNA immunization by targeting ASFV antigens to SLA-Ⅱ bearing cells[J].Vaccine,2011,29(33):5379-5385.
[22]	PÉREZ-NUÑEZ D,SUNWOO S Y,SÁNCHEZ E G,et al. Evaluation of a viral DNA-protein immunization strategy against African swine fever in domestic pigs[J].Veterinary Immunology and Immunopathology,2019,208:34-43.
[23]	SUNWOO S Y,PÉREZ-NUÑZ D,MOROZOV I,et al. DNA-protein vaccination strategy does not protect from challenge with African swine fever virus Armenia 2007 strain[J].Vaccines,2019,7(1):12.
[24]	JANCOVICH J K,CHAPMAN D,HANSEN D T,et al.Immunization of pigs by DNA prime and recombinant vaccinia virus boost to identify and rank African swine fever virus immunogenic and protective proteins[J]. Journal of Virology,2018,92(8):e02219-17.
[25]	LACASTA A,BALLESTER M,MONTEAGUDO P L, et al.Expression library immunization can confer protection against lethal challenge with African swine fever virus[J]. Journal of Virology,2014,88(22):13322-13332.
[26]	ARGILAGUET J M, PÉREZ-MARTÍN E, NOFRARÍAS M,et al. DNA vaccination partially protects against African swine fever virus lethal challenge in the absence of antibodies[J].PLoS One,2012,7(9):e40942.
[27]	LOKHANDWALA S, WAGHELA S D, BRAY J, et al.Induction of robust immune responses in swine using a cocktail of adenovirus-vectored African swine fever virus antigens[J].Clinical and Vaccine Immunology,2016,23(11):888-900.
[28]	LOKHANDWALA S, WAGHELA S D, BRAY J, et al.Adenovirus-vectored novel African swine fever virus antigens elicit robust immune responses in swine[J].PLoS One,2017,12(5):e0177007.
[29]	LOPERA-MADRID J, OSORIO J E, HE Y, et al.Safety and immunogenicity of mammalian cell derived and Modified Vaccinia Ankara vectored African swine fever subunit antigens in swine[J].Veterinary Immunology and Immunopathology,2017,185:20-33.
[30]	CHEN X,YANG J,JI Y,et al.Recombinant Newcastle disease virus expressing African swine fever virus protein 72 is safe and immunogenic in mice[J].Virologica Sinica,2016,31(2):150-159.
[31]	CADENAS-FERNÁNDEZ E,SÁNCHEZ-VIZCAÍNO J M,KOSOWSKA A,et al. Adenovirus-vectored African swine fever virus antigens cocktail is not protective against virulent Arm07 isolate in Eurasian wild boar[J]. Pathogens,2020,9(3):171.
[32]	步志高. 非洲猪瘟防控与疫苗研制最新进展[J].兽医导刊,2021(13):6-7.